Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If the judge issues something to that effect, minus the limitations of where they can trade which would not be applicable in our case, I would be happy. It's obviously a completely different case, but the monitoring closely of the defendants trades in NWBO with all the tools available would be a good place to start. The added scrutiny can only benefit NWBO.
To begin with, I find it interesting that the shorts seemingly now only use OTCN as their tool to trade. They have probably decided not to use the 7 MM's named in the suit in order to avoid unnecessary oversight.
All your favorites!
Thank You Administrator who bailed me out.
I truly think that they would have left the MM's and their greed alone if May 10, 2022 had not happened. It could have been the straw that broke the camels back. At that time they knew they had great results and was waiting for the market to acknowledge these results. That makes me think that anything surrounding AF and his actions involved in and around May 10, 2022 could come out in the open soon. I would not be surprised to see his name being brought up as we get further along.
Also, I have always had such a hard time understanding shorty's play with keeping down the SP when shorting and if Shorty truly believes that NWBO is dead in the water. Why not let it run and then short at higher prices in order to have the opportunity to make more money. They have done that successfully a few times the last two years. I can think of only a couple of reasons. They know that it will not be possible for them to execute bear raids like they have in the past. They were relying on an assist from MM's in keeping the price in check and moving the price down. They probably feel now that they likely will not have that going forward. But why did they feel and act like 0.92 is their "Custer's Last Stand" and used a little over a million shares and close to $1M to keep the price at or below that level. I did also notice that they were also the big buyers at any price under 0.92 towards the end of the day and likely a few at 0.92 right at the end. Are they getting close to a price where they will receive the dreaded margin call? They could be. They are likely walking a fine line between selling and buying.
JMHO
Just a few observations.
We have been in a situation since yesterday, where shorts are working overtime to keep price down. I would imagine a few of the MM's are buying shares to lend out at higher levels. They are charging up to 17% for shorts to borrow the shares. Why would they have raised the cost of borrowing? Simply because they can. I understand that if you call your broker and ask what interest rate you can get, they will tell you a number in the single digits, but that is not the cost to the people wanting to borrow the shares. The fact that they are able to lend out shares at this rate, seems to suggest that these shorts are desperate, that they are getting close to being over leveraged and also that they are hoping the borrowing will be short term. You can see that using OTCN is the tool for the shorts. They have been the lowest ask for 99% of the time since yesterday. Every time they take a breather, the stock moves up. Let's see how much ammunition they have and how much they are willing to burn. It's definitely going to be an interesting afternoon.
The fact that the 7 MM's have been put on notice about their spoofing doesn't mean they won't trade in the stock. Their algo's are still working overtime to make money trading the stock. They will likely not assist the shorts in the bear raid as they have done previously.
In regard to yesterdays question about a Merck and NWBO deal, I want to make it clear that I don't think a deal has been signed. I think a framework of a deal has been made, depending on the success of the Merck sponsored combination trial result.
I spoke to two Apes yesterday and they said that they are working to get NWBO on the Apes radar. It will take time. As for the Robinhood problem, they seem to think the majority moved out of Robinhood after the GME debacle and are likely with bigger brokers now. They seemed really pleased by NWBO's lawsuit as they understand that it was the driver behind yesterday and todays upward movement in AMC. They also said that the whole Ape system is not as centralized as people might think and that NWBO interest would hopefully grow over time.
I hate to say it, but I am pleased we didn't get MIA news this week. We have been able to use the lawsuit and the support that have garnered to start the move. I hope we get the news Wed or Thur next week. That will give the lawsuit a little runway by itself and hopefully we will learn something from Dr. Liau's webinar on Monday. It will also get the Apes some time to get on the NWBO bandwagon, just in time for the MIA. I know this is wish thinking, but one always have the right to be hopeful.
Thanks for the support shown yesterday in regard to my 1 post limit. I had way too many violations, with most of them being off topic. I should have stopped linking to posts on other boards that implied the reason for posters on this board. For that I am guilty.
Enjoy the weekend.
"It's a beautiful day in Zamunda"!
It is nice to see management being proactive today and creating a runway for future news. I have read the lawsuit twice and as a law school graduate, I am very impressed with it. There's just enough mentioning of patients in there for anyone reading this to understand the third party implications of the acts that are being alleged.
I think it is nice to see the stock trade in a relatively normal fashion. Retail and traders buying and a few traders likely selling for pennies and Shorty trying to keep the price down. That's how the market should work. Adding 300BPS to the cost of borrowing also brings a smile to my face. Not sure when we will see a more realistic valuation of NWBO, but the lawsuit news should bring in more retail and traders as the news of it spreads throughout the next week or so. This is 'free' advertisement to a market that is sick and tired of MM's and HF's screwing the little guy and in our case the patients too. I think the trading in the next week or two will be volatile as the shorts will not give up easily. It will be a lot harder for them now that they don't have the cover of MM's to assist them in the bear raids. I sure hope that we see a change from the MM's and not just short term until the 'dust settles'.
I have a question in general for the board. I will not be able to respond to this as I am only allowed to post once a day due to my previous violations of the rules, for which I am extremely remorseful (should any administrator read this).:
Do any of you think that there's not already a deal done (or at least outlined based on the combination trial) with Merck? Do you think they are going to sponsor a trial with Murcidencel without any guarantees from NWBO that they will have access to Murcidencel if the trial is successful? Do you think they will sponsor a trial with the knowledge that BMY or any other company could come in and buy NWBO, leaving them without access to Murcidencel? I would think that they have at least gotten a guarantee from NWBO that they will have future access to Murcidencel, in one form or the other. It doesn't have to be an exclusive partnership guarantee or a buy out promise, but they would at least have gotten a non-exclusive right to use Murcidencel with Keytruda if trial is successful. JMHO
As I am writing this, I can see we have moved up 3 cents during my longwinded post, which is always a good sign.
See you all tomorrow. Enjoy the good news and have a nice glass of wine tonight. Let's hope the market the next few days look at this as favorable as I do.
While we wait for something to happen, it looks like the MM's have decided (for now) that we will stay in the 0.83-0.85 trading range. We might see a few attempts to break the lower end of that range, but we might also see an attempt to move it up. CDEL have been support and frankly I have no idea if they are buying to cover clients or to have shares to keep the upward momentum down. One thing is for sure, they have gobbled up a lot of shares, even at these low levels of volume.
I am still of the belief that we could see the MIA any day now and that this could spur a seldom seen PR from NWBO. As for the other rumors, I have not myself been able to find any support for them. I have a few friends who are desperately calling their friends to find any little bit of knowledge they can, and I will gladly share if/when I get some info that is not considered inside info.
I was pointed to NWBO by someone who had a long time working relationship with NWBO as a third party service provider. They put their working relationship on hold when the trial ended. That person was very certain to let me know that NWBO was a 'legacy' project for LP. How to use that information is up to each and every one. I take it to mean that she will be involved through approval and maybe even through commercialization process.
I will remain patient and watch the next few months play out. I am looking forward to the LL webinar on Monday, but only from a science perspective and with no expectations that anything she will reveal will have much influence on the short term SP. I do believe that she is now completely free to discuss a multitude of things we all want to know about, UNLESS she is in the process of writing another article for JAMA that has her embargoed about secondary endpoints and the combination trial.
I really don't know if we get any more info from NWBO, outside of a potential MIA cert acceptance prior to the definitive proxy or the ASM, but here's hoping.
Have a wonderful day.
Daily post.
I don't have much to add to the riveting conversation from today.
I do think that the C-shares could be used if an equity partnership was in the works, which I highly doubt at this time. There's very little likelihood that an equity partner would ever convert their 'Preferred' C-shares to common stock.
I definitely do not think that management is using the proxy vote as a way of doing an R/S 'without blame'.
I don't think 'the market' in general perceived the ASM PR as negative news. I think that today showed ample support and it will be interesting to see what happens the next few days. I think that some of the support today was from shorts covering, which is never good as they would have shares to short in the event the SP starts moving up.
For someone like me who have been skeptical about technicals, todays move down to close the 0.82 gap was interesting. The MM's do likely look at least a little to technicals, it seems like.
Finally, I was told that one of the rumors that has been churning around in the biotech financial world has been 'somewhat' confirmed!!! The only thing is that I have never been told what rumors were swirling and likewise has not been told which one has been 'somewhat' confirmed. My two biotech analyst 'friends' are a couple of bastards!!! LOL This last paragraph likely makes as little sense to you as it does to me, so I am not holding my breath. I will not believe anything until I see the actual information, so this is not a Pump. I actually was cutting and pasting this a few times before keeping it in the post. I am sorry if this leaves you more confused than before.
Enjoy the week and let's see where it goes.
A brief version today as it is Sunday and hanging out with my grandkids.
I am all for people voting their conscience. I hope people do take the time to understand what they are voting for as any vote has consequences. I am 100%!!! certain that NWBO will NOT go into bankruptcy if they do not get the vote to raise the authorized share count. I am also fairly certain that they are not bluffing when they mention that the alternative is an R/S. They would not have mentioned this if they were not serious about making sure that the AS number could cover their options/warrants obligations. I can't help thinking that this is due to something they are working on. They really didn't need this (which was why I thought they might hold the ASM without this proxy vote) as a majority of the warrants/options could be extended and they always had the 100M preferred share to use (among them 9M the c-shares). The mentioning of the R/S as the only viable option should this fail, makes me think this issue is important for them to get resolved in a timely manner for reasons I can only speculate about. I have never been adverse to an R/S if done right and for a company on a positive path, but I am still voting yes as that is the path selected by management who are privy to information that I am not. That being said, people should be entitled to vote their shares as they see fit.
Still a lot of rumors out there in biotech finance land, that my friends have not been able to verify, so for now, they remain just rumors for me. I think that we could see the MIA cert this week, as it likely is not state secrets as to when the inspection took place. I do not think we will get any news about a partnership in the next few days, but hope that some of the buzz around the combo trials will get us some news either December 5 or sooner.
Hope you enjoy what is left of the holiday weekend and that we see the market read the ASM news as a positive which I think it is. JMHO
Daily observations.
First off, I was wrong in MY OPINION that I didn't think they would raise the AS if they had an ASM this year. That was my own opinion and not a 'Campfire' story. My opinion was purely based on the preferred C-shares and nothing else, which I will talk about below.
In regard to the upcoming ASM, I will vote yes prop 6. I think it is the right thing to do as it is needed at this time. I know several shareholders with a lot more shares than myself and they are all voting to approve the raise in AS. I find it interesting that some of the posters who have been furiously against an R/S have stated they might vote no. That would be guaranteeing that we will see an R/S in the future. The company has even said so much: "the Company needs to either amend the Certificate of Incorporation to increase the number of authorized shares or implement a reverse split of the Common Stock." That could be scare tactics, but those who have read my previous posts, I do not see an R/S as negatively as others when done at the right time. I find it funny we have investors that do not understand the difference between authorized and issued and think the raise is a dilution.
I will also vote yes on the election of directors and likely on the ratification and approval of executive compensation.
In regard to the 500M raise in AS, I think that is a reasonable number. We currently have around a little less that 1.5B shares potentially issued when fully diluted (already issued plus options and warrant liablities). I am not including the 24M potential shares from the sold C-shares, as there's no saying if they would ever be converted. That gives them 200M shares of Common stock that is authorized but not issued. In addition they have the 100M preferred share to play around with, where 10M have been authorized as series C shares. Reviewing the document creating those shares, I saw that they were non-transferable EXCEPT when authorized by the board. I think that in the event of a partnership, they could use the C-shares as the shares to sell to the partner. I think that 10% would be a good percentage of the company for a partner to acquire. That would be just under 8M C-shares. A partner would not have any need to convert those shares to common stock and thus the c-shares would not impede in the 1.7B cap on common stock the company can issue. They would want to keep them as 'preferred' with all the benefits that entail versus common stock. The have the potential, currently, to issue up to 90M additional preferred shares as the articles of incorporation allows for 100M preferred shares in addition to the common stock shares. These could come in handy at a later time.
Personally, I think the ASM announcement is a positive. That is just my opinion. I do not have any idea how the market in general will perceive it. It seems like those fighting against NWBO use every news event to try to move the price lower. I do not know if they will do it this time, but they have proven that they can if they want to. I do think that with the JA out, they are either being careful or there's more support from the market in general. The daily SP is not a concern of mine, so this issue seems irrelevant at this time for me.
I am still not in the camp of a buy out will happen, now or in the near future. The raising of the AS from 1.2B to 1.7B does not in itself preclude it. It would actually be a sign that it was a possibility, due to the fact that after the raise, they will have enough shares to issue which is important in a BO/Merger. BUT the current SP is in my mind a close to 100% guarantee that it won't happen. LP is not selling NWBO at this or anywhere near this level.
I do think that a partnership would still be an option. I have mentioned how I would like to see such a partnership structure and to me that is still the best option. $x upfront. $x for milestones. Maybe $x for x amount of shares (maybe 10% of the company at a price either pre-determined or at a certain date) and a profit sharing for perpetuity (BMY paid NKTR 65% in their setup for exclusive rights for 9 indications). Merck is still my favorite, based on Duffy, the value it can bring to Keytruda and the fact that Keytruda seems to be the checkpoint inhibitor with the best results in most indications. That doesn't exclude others from being in the mix.
I think that at least one thing, if not more, will need to happen before any deal can be announced. We need to get the MIA for Sawston. That is almost a given, as any partner would want to know that commercial production of Murcidencel is in the clear before paying out money for a partnership. I think that could literally happen any day now.
We might also actually have to have the shares available (ASM and a yes vote for raising the AS). If the partner is Merck, they might be waiting for news from the combo trial. I remember that at this time last year, a few posters were hoping for some form of intermediate results. Now that the results of Murcidencel has been announced, it could free up the release of some new about the combo trial. As I am not a scientist, they might have to wait for approval of Murcidencel before they can release any news, but I don't know. I just know that people more involved with the science were hoping for some news last year.
Sorry for the longwinded post. JMHO. I am an easy target to argue with as I am not able to respond. Hope your Thanksgiving was amazing and that we see some positive signs in the near future.
Slightly shorter than normal daily observations. (sorry, I started rambling again, so became longer than anticipated)
No significant change in the legal outstanding shorts as of 11/15/22. Still slightly above 27M. Doesn't look like the shorts were expecting positive results by SNO.
Still quite a few rumors going on regarding a deal in the works. Not jumping on that wagon yet, but as previously mentioned, the BMY/NKTR deal setup seems perfect for all parties should a deal be in the works.
No news about MIA this week (so far), so hoping for next week, though I am not predicting, just hoping. Think this is a MUST have milestone prior to any deal.
I have been trying to think about how and what NWBO management could communicate at this time without saying much, but everything I have come up with would be information that likely should be avoided at this time, if they are working on something important behind the scene. I do wish, like all of you, that they start singing their song as this silence is deafening and hard on all of us, even me, who is not planning to sell for a long time (at least approval, but likely not until income starts rolling in).
I have never been much of a pro technicals for NWBO. It does, however, look like the traders and MM's do pay attention to the technicals and that they could be somewhat relevant at this time. I have always been thankful for our two Stallworth's of charts and appreciate they continuous efforts to show off their skills.
ASM! Never thought that this years ASM would have any proxies for raising the AS count. I would not think that they would have a vote IF they were considering an R/S with uplist, as I doubt they legally have to ask us. If they enter a partnership, that also seems unlikely for a vote as they are not changing the status of our shares. All in all, I highly doubt they will have a proxy if they do have an ASM this year. I, personally, do not see a need to hold one, but would likely attend if at a reasonable place to visit.
At least the short term longs who focus on daily SP, should have a nice weekend with the downward trend having stopped and they can enjoy a 5% up day.
Have a safe weekend
Daily observations.
I want to make it clear that I am not predicting any Buy out or partnership in the near future. I do think there's a little chance it might happen (not a traditional buy out). I was merely pointing to an example of how a potential deal could be done that would satisfy both sides at this point in time (SP at an artificially low place).
We do need the MIA before anything like this can happen. I think there's a good chance this will be issued within the next couple of weeks. Without it, there's zero chance anything like that will happen.
I am not in the camp that an ASM has to happen shortly. I never thought they were going to ask for an increase of AS at this time and any other corporate maneuvering they could be working on in my opinion does not need shareholder approval.
The speculations that not having announced the ASM and no longer having a relationship with Powerscourt is a sign that a deal is imminent, are just that, speculations. I understand that a deal would be one explanation for those things, but that does not automatically prove that this is what is happening. I do not think at this point we have had any confirmation that the company is in a quiet period. I have seen a cryptic answer from DI that was interpreted as such, but based on his previous replies to messages, I would not put too much value of the wording in this particular reply.
My viewpoint on Optune is that it has seen it's best days with the results of Murcidencel being released. I trust Dr. Brem in his assessment of potentially being helpful vs GBM, but with an alternative that provide better odds and a heck of a better quality of life, I think the days of the helmet will soon be over. I have not seen any anecdotal evidence that a combo with the helmet works, so I will leave it at that.
I think most of the shorts not associated with Crocodile Dundee and the poli-sci major have covered.or are in the process of covering. Shorting, in general, requires a firm understanding of fundamentals and since May 10 and specifically since the JA, those negative fundamentals are simply not there. The remaining shorts have hedged their wagon to the personal vendetta against LP and NWBO and very few have ever been successful when acting on pure emotions without a solid underlying fundamental support. In regard to a trheatened paper on his underlying fundamentals for his short position, I think that should be welcomed. I seriously doubt he will publish it and if he does, it will likely just be a recap of the Statnews article, as he seems to follow the Poli-sci major blindly. JMHO
Most of us longs who are not worried about the daily SP but are feeling good about the longer term prospects of NWBO will have a nice and relaxed Thanksgiving. It is my hope that those who daily posts their doom and gloom whenever the SP fluctuates will soon realize that the daily SP for an OTC stock is meaningless in the big picture and that we are at a point in our investment thesis where we know so much more about the science and the incredible reception in the medical community for the results of the trial.
Not much for predictions, as I have learned a lesson or two from my experience with NWBO and the OTC, but I do believe that we should be on a regular exchange and be more fairly valued in 6 months time, hopefully a lot sooner. I think (hope) we will all be very pleasantly surprised by the corporate developments that will happen over the next month or two. I have always said I will defer my critique of management until I have more information about what has transpired with the company, but I would be disappointed if we don't have any significant corporate developments before the end of Q1 23.
Happy Thanksgiving to all of you and I hope you truly enjoy the day with your loved ones. This will be my first Thanksgiving without my two grandkids (5 & 6), so mine will be a little lonelier than normal, but will try to make the best of it and feel thankful for all that I have.
Daily observations.
A general observation: What an amazing amount of support NWBO, LL and Murcidencel have received from the medical community since the JA. This, however, has not translated into a rise in the SP. The bear raid was successful, but I have to believe they have been disappointed with their ability to add shares to cover. I think that retail has been adding instead of selling and that has severely limited the number of shares they have been able to add. I have no access to detailed information, but have been told that CDEL have been the most aggressive buyer on the way down. They are likely the one MM who have had the biggest short interest clients, so only natural that they are the most aggressive buyers. I can see the SP move back up as we get closer to the end of the day. As I am writing this, I can see that it is slightly up, which is good, but my thought was that they would try to close the gap at 0.82, so I did not get to add more this morning.
Buy out or partnership: I have been told that the rumor mill is amp'ing up in this regard. I see a lot of posts that talk about BO and how any BP would pay 20x over the current value of NWBO. THEY WILL NOT. I think that if you take a careful look at the BMY/NKTR deal from 2018, you will see a frame work that would be perfect for NWBO and a BP. A decent amount up front, milestone payments and a profit sharing for all future revenue. Whomever will win the BP battle for control of Murcidencel does not have to own NWBO. They just need to control the use of Murcidencel, they do not need to 'own' NWBO. If this is Merck, they just need to know that they can control the use of Murcidencel and thereby extend the value of Keytruda for years to come. This set-up would do that. The BMY deal were only for 9? indications and NKTR were free to use their drug in other indications. Now Merck would likely not want to limit the indications and NKTR drug was only in P1/2, so you can add figures to that deal to get to where an NWBO deal would end up.
BMY Deal
What needs to happen before we get news of any deal. IF there really is a deal ready to get signed, I would assume that at least two things have to happen before it can be finalized. The Journal article being one and the Commercial production certification is likely the other. As many of you, I am constantly checking MHRA for the cert. It looks like they post most of them on Tuesday and Thursday evenings after the close of the US markets. Let's hope we get this cert. either this week or next week as the average time for issuing of these certs have elapsed and we could see one soon.
I also have noticed that some people are speculating that becoming 'another' company via a merger could be happening. Pre-covid, SPAC's were the rage of Wall Street. Now people are realizing that even though it is much faster than an IPO, they are very expensive for companies as the cost of managing the Spac's are fairly high and likely not worth it. I do not think this is the way they would go, but who knows.
Again, Just my humble opinion.
Just a few observations.
I was planning to add a few shares this morning. I haven't yet, as I thought the opening volume was weak and wanted to see where we were going. I will never hit the bottom as I always look to buy when SP is moving upwards. I will add when/if it starts moving up 4-5%, so likely around 0.90 on the way up if we do not go any lower right now. EDIT. Started buying at 88/89 just now 11:28est
I was a little surprised of the extend of the bear raid yesterday and continuing today. They do it because they can. Didn't think they had the balls to do it, AF article or not. That being said, CDEL have been staying away from the selling and adding at all levels. I don't know if that is covering for their clients or because they want to have shares when the price begins to move up again. I have more faith in them when it comes to being in the know, than the other MM's. I think traders have gotten crushed these last few days, which is never a good thing as they are instrumental in any upward movement of SP. Retail longs by themselves will not be able to move it up much without the help of traders.
I have been told from people in the biotech financial industry that there's a flurry of rumors going on about both BO and partnerships. As the saying goes, where there's smoke there's fire. That doesn't mean they will come to fruition, but that there likely are talks ongoing on both fronts.
I have gotten some grief about my statement that it is possible for them to uplist overnight, even in their current situation. People can believe it or not, but the last few days of trading should be a good reason why this option should be on the table. My sources have again confirmed to me that this is an option. I personally think that the reason this has not been on the radar before is that it would be very risky before the journal article as you need to be in a good place when doing this as it includes an R/S simultaneously. Not sure if these bear raids are a negative in this scenario as it does not send a sign of positive things to come. Maybe that's one of the reason they are working so hard to keep it going.
JMHO. See you tomorrow and GL to all.
I am sure a lot of long term NWBO investors prepared to trade this stock this morning when the negative article was published. I for one decided to 'play' a little with my retirement account shares as they do not have the same tax implications as my regular portfolio. My timing was awful, sold at $1.20 and bought back at $1.08, not anywhere near high and low. I am still happy for the added few thousand shares. I do think we could end the day relatively flat in the $1.10-1.18 range. JMHO
Personally, I think that they are well into the application for approval process, so don't expect any news in this regard in the near future (2-4 weeks).
I think that the next milestone will more than likely be the MIA for Sawston. It could literally come any day.
I would love for us to get some results released from the combo trial, as I know some who have been expecting this for some time. I think they had to wait for the JA to get published before they wanted to talk about the combo trial, as it gives them a solid idea of the future of approval for Mucidencel, which is important as it is the central drug for the combo trial.
I doubt it will happen, but an uplisting overnight (either with or without an R/S, depending on SP) would be nice. Regardless of what Ex says, I have been told by attorneys who specialize in listings that this is absolutely possible.
Further down the line, I expect we will get some MAA and BLA news, as I expect we are well into these processes.
Also, we could see additional journal articles with a more in depth discussion of the stats.
Other than that, I do not think that NWBO will be bought out for some time and I think that management need to let this permeate for a little while before putting ink on any JV or partnership. As the news spread and the SP hopefully moves up on this, they would likely be in a much stronger position later this year or earlier next year.
JMHO
Observations from a limited poster.
Until we see the general investment community jump onboard with some serious buying interest, we will be at the mercy of the market makers. They have plenty of shares to do whatever they want at this time. Increased volume will make that harder and harder for them.
Would love to see an after hours PR in the next few weeks (they have a 10 day notice requirement from FINRA, so unless they were 100% sure they would get the JAMA article out yesterday, I think we need a week or two) that announces a 1 for 10 or 20 reverse split with same day uplisting to NYSE. That is one thing that would bring about the upside to the SP we all want to see. I am sure the MM's have good connections in FINRA, so they would likely have a heads up. The SP movement yesterday and today 'could' be a sign that something is cooking and that they are desperate in getting shares at these levels.
JMHO. Will be back with my 1 daily post later tonight or tomorrow morning.
JAMA!!!
Guardian article says that the results were published today in JAMA!!!
Maybe this guy jumped the gun.
I think the retracing today was predominantly traders taking profit (who can blame them when sniffing 40% profits in just a few weeks) and the people looking to suppress the share price taking advantage of that.
Sleeping like a baby at night when seeing desperate posts with outrageous claims and absolutely zero facts or documentation to back it up.
I was somewhat wrong in my assessment of the immediate outlook for the share price. I thought that they would be able to keep suppressing the SP under $0.80. That being said, the upward move is very welcome for all of us. The day traders are obviously back now that we have gotten a much higher volume. That should be evident when you look at the spike followed by profit taking. I, personally, have not jumped in as I do not want to be caught with the hand in the cookie jar.
The quality of the negative sentiment on social media against the NWBO investment narrative is not something that keeps me up at night.
Just my observation on a very interesting day. MM's have sold well over 500k shares at 0.799 or slightly below in last 90 minutes. I can't tell if it is intra MM trading or if it is a short position or two trying to keep the SP down. In the past, they would have let it run because they felt certain that they could suppress the price at a higher level. It seems to me that they are aware that severe price suppression is likely not something available to them in the future, so they are either doing a last ditch attempt to cover, which is failing if it is retail buying their shares and holding, or they are preparing for a last ditch bear run. If it is just MM intra trading, they are trying to see if retail will fall for it and sell some shares because it looks like it won't go any higher in the near future. It is really interesting to see and I do not think they will let it run prior to any serious news. I do not see the $1+ level getting there prior to news. I have felt pretty confident that they have been trying with all their might to cover at these levels. Just because the official short number has not gone down, it doesn't mean they have not covered. They are likely holding on to their borrowed but covered shares and willing to pay the interest rate so they have shares to use now and for future attempts to suppress at higher levels. I highly doubt that there's actually over 20-M shorted shares at this point. It is in their interest to artificially keep the official number higher and not look like they have been covering.
JMHO
Some observations for my one daily post:
Why is the name change done for this conference? It seems to me that they could have continued to use DCVax-L until it became important to change it. It would avoid any confusion the name change could potentially create. One reason could be that the JA uses that name and they needed to use it here in order to not create any confusion when publication hits. JMHO
I have mentioned before that I didn’t see any huge upward movement prior to news. I think that is still the case as the shorts are continuing to cover (I think they are covering but not returning the shares, being willing to pay the interest rate for the chance to use the shares to suppress and for daily shorting). JMHO
Murcidencel will not be the commercial name, but is the generic name they have gotten approved. JMHO
I think that they are and have been in constant communication with MHRA and FDA and that in both jurisdictions there’s a rolling submission going on as we speak. JMHO
Finally, I think that the appearance of the 10 new authors is a good sign that the JA is not far out in the future.
You are right, but according to my biotech sources, the latest SOW has 99% nothing to do with the application for approval. It is likely related to longer term manufacturing output and is not that time sensitive. I agree that everyone is guessing, but I do have faith in the experts I know and what they tell me. I was also told not to put any importance on the September 23 date and that the timeline has not changed. I can only relay information that I have received and it is up to everyone to decide what their opinion on the subject matter is.
I am limited to 1 post, so any responses will have to be tomorrow.
Let’s see what the next 10 days bring and if we get the MIA before LL speaks. As far as I remember, you had mentioned that it would be right around this time if they hit the average time for this process.
No surprises. Glad to see they are moving along in the approval process.
I really don’t know how brazen they will be, but I do think that they are going to be less aggressive than previous based on the fact that they are not letting it run at this time. If they thought they had enough power to move it back down, they would likely have let it run up like before. There’s a lot more knowledge now than during previous run ups, so they could just be trying to suppress and cover like they have been until news happens and then just try to cover whatever amount they still need to at the time of the news. It will be interesting to see what happens. JMHO
It has been my view that a lot of the legal shorted shares are bought back at this time but not returned. They are using them for the daily price suppression and could be using them to short again once the price moves up. I have no opinion on any potential illegal shorting.
It always strikes me why people are worried about information regarding their lives. I could care less who spies on me as I have nothing to hide. If someone in government wants to waste time with keeping an eye on me, their lives are pretty useless.
As I have expressed a couple of times before, and this is solely my opinion based on my experience, I highly doubt we will see an anticipatory move this time around. Even with the higher likelihood of JA and official TLD within the next few weeks. The shorts know that they need to cover and will use every tool in their arsenal to keep the SP lower until the market start buying shares at a pace where they can no longer resist. That will likely not be before any actual news and might even be a day or two after news breaks.
I don’t think this matter is important anyway, as it was the shorts who pumped and dumped with the victims being the unsuspecting traders and retail investors. The company would have been in this same position without those 4-5 weeks of pump and dump.
From a legal perspective it has no relevance as AF clearly knew he was not reporting the truth based on his awareness of the situation as he expressed in prior tweets and communications. What the unchanged trial points did was give him a cover in relation to those reading his article.
I am 100% sure that the AI in all my social media is pissed off at me because I only see the posts of complete morons.
Still think the best chance of a JA in the near future is Journal or Neuro Oncology SNO22 edition. JMHO.
I don’t think anyone has said that CRL’s manufacturing capabilities are solely related to DCVax-L. It does however imply that they would be able to produce DCVax-L if need be and NWBO has a deal or gets a deal with CRL.
Yes, we should be fine with production capability in North America and they can also provide assistance to Advent in EU should that be needed. The 1k a month is what Sawston is ramping up to, and CRL will be on top of that number.
That’s hard to say. Normally I would say that there’s a chance of an anticipation move, but as the Market Makers are aware of where this stock will head once news are out and the general investment community gets to know about NWBO. I don’t know if they are assisting their short clients in covering or if they are accumulating so they can profit when news comes out, but for the last many weeks there’s not been much new money coming in and not many shares for sale (other than market makers keeping some liquidity in the daily trading). I really don’t think we will see much upward movement until news. This is obviously just my opinion based on the daily trading patterns.
I think that depends on how MM’s view the future prospects of company success. I think that they were part of the upward movement prior to NYAS as they didn’t think any sustained price levels were going to happen. Right now I think they are aware of the inevitable success and will keep a clamp down of the SP for as long as they can. I doubt we will see too much new money flowing into the buy side prior to news, so not anticipating any huge movement before at least the abstract is released. JMHO
You should feel blessed to know about NWBO before the rest of the market. The reason we don’t see much movement in general is that not many people know about the company as they have not been able to make their case heard at this time.
General understanding of how these conferences work.
What are the odds that the JA will be in Journal of Neuro Oncology? That is the SNO journal and the journal of mostly every neuro oncology society. It would likely be in the 2022 SNO edition. Just wondering.
Absolutely not. We don’t need someone who will try to change the company strategy. We need to let things play out and move up organically. This is my gut feeling and will be until we see what happens when they start ‘telling’ their narrative once news come. If we can’t move organically on JA and the other news items we are expecting shortly, then I will have to reconfigure my thoughts on this, but until then I am fine with how we are progressing.
It has been clear for a while that It is the combination trials that will be the key to the future. For people here to say that BP is not interested in NWBO, is complete ignorance. Any BP that would benefit from the combination trials is lying in the wait for NWBO to reach a valuation that will make it interesting for LP to entertain offers. They are well aware of the fact that controlling interests have absolutely no intention of giving away NWBO.